Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with doce40

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with doce29

Views

Views
January 20250
February 20252
March 202515
April 20252
May 20250
June 202510
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore15
Hong Kong10
United States2
Germany1
Spain1
 

Top cities views

Views
Hong Kong10
Council Bluffs1